Introduction
Bispecific antibodies (BsAbs) offer significant new opportunities to intervene in disease mechanisms (Huston et al., 1996; George and Huston, 1997) , even with existing validated targets such as Her2 and Her3 (Kipriyanov et al., 2002; Kufer et al., 2004; Robinson et al., 2008) . Novel formats include dualspecificity variants of Herceptin that bind Her2 or VEGF with the same binding site (Bostrom et al., 2009) , dualvariable-domain IgG that bivalently binds two distinct targets (Wu et al., 2007) , CRAbs that chelate a target at very high affinity with a linked pair of single-chain Fv (scFv) to nonoverlapping epitopes on the target protein (Neri et al., 1995) . Examples of their diverse applications targeting stratified disease through dual specificities and enhanced avidity (Vallera et al., 2005) , blocking fungal infections with tandem bispecific domain antibodies (De Bernardis et al., 2007) , directing a cytotoxic agent to a target cell (Cao and Lam, 2003) and bridging an activated cytoxic lymphocyte to a target on diseased cells (Perez et al., 1985; Kipriyanov et al., 2002; Gall et al., 2005; Hammond et al., 2007) . Approaches to create therapeutic BsAbs include chemical crosslinking (Brennan et al., 1985; Glennie et al., 1987) , tandem fusions of scFv or V domain antibodies (Atwell et al., 1996; George and Huston, 1997) or their fusion to the C-or N-terminus of heavy chains (Coloma and Morrison, 1997; Shen et al., 2006) . Bispecific IgG antibodies have been made in hybrid hybridomas, termed quadromas Cuello, 1983, 1984) , but the complexity of species produced in cell culture makes purification difficult and expensive (George and Huston, 1997) . There remains a need for engineered bispecifics with superior properties that can be readily produced in high yield from mammalian cell culture.
A heterodimeric Fc region with its essential effector functions intact is the preferred vehicle for engineering therapeutic BsAbs that retain the generally optimal properties of human antibodies. Knob-in-hole C H 3 engineering was the first approach toward this goal (Ridgway et al., 1996; Atwell et al., 1997; Merchant et al., 1998) , which achieved good heterodimer expression from mammalian cell culture. However, optimal stability required introduction of a non-native disulfide bridge between the C H 3 heterodimers (Merchant et al., 1998) . This investigation describes the first antibody engineering approach to convert Fc homodimers into heterodimers by interdigitating b-strand segments of human IgG and IgA C H 3 domains, without the introduction of extra interchain disulfide bonds. Expression of SEEDbody (Sb) fusion proteins by mammalian cells yields Sb heterodimers in high yield that are readily purified to eliminate minor by-products. In the present investigation, fusion partners were typically added to the N-or C-terminus of one Sb chain to facilitate analysis of heterodimer formation.
Materials and methods

Molecular modeling
Molecular modeling was performed using both Insight II and Modeler (Accelrys, San Diego, CA, USA) running on an SGI Octane II workstation, or RosettaDesign (Misura et al., 2006) running on a PC with a Red Hat Linux operating system. Root mean square deviation (RMSD) calculations were performed and molecular models for figures were generated with PyMol (DeLano, 2002) . The Fc structures used for modeling the SEED C H 3 structures and for determining RMSDs were PDB ID numbers 1L6X (IgG1 Fc) (Idusogie et al., 2000) and 1OW0 (IgA1 Fc) (Herr et al., 2003) . The interface residues of IgG were defined as any residue whose side chain was within 4 Å of at least one atom in the partner domain, using the 1L6X crystal structure for calculations.
Gene synthesis, expression and purification of Sbs AG Sb and GA Sb DNA sequences were designed, as described, with flanking sequences for restriction enzyme digestion and cloning. The genes were synthesized by Blue Heron Biotechnology (Bothell, WA, USA), and inserted into pdCs (Lo et al., 1998) (for GA Sb . AG Sb-IL2) or pdHL mammalian expression vector (Gillies et al., 1989 ) in place of the C H 3 domain for the monovalent Sb. For the IgG -IgA chimera, the DNA sequence for human IgG1 hinge-C H 2 was joined to that of human IgA1 C H 3, with the junction at the common glycine (residue 341 in 1L6X and 342 in 1OW0). Control IgG1 and its Fab genes were obtained from the EMD Serono collection of immunoglobulin genes.
Transient expression of protein was achieved by co-transfection of HEK-293T cells using Lipofectamine 2000 (Gibco C/N 11668-019) according to the manufacturer's protocol. After transfection, the cells were incubated for 2 -4 days at 378C for protein expression, the supernatant harvested, passed through a 0.22 mm filter and stored at 48C. Sbs were purified by batchwise adsorption overnight to protein A beads (Pharmacia), and eluted in column mode by addition of 400 ml 150 mM NaCl þ 50 mM sodium phosphate buffer at pH 2.6, with collection in a tube containing 400 ml of the buffer at pH 9.0.
For stable expression of Sb heterodimer proteins, mouse myeloma NS/0 cells were transfected by electroporation and stable clones were selected in a medium containing 100 nM methotrexate (Lo et al., 1998) . Stably transfected cell clones were selected to both optimize overall yield of protein and maximize the percentage of heterodimer protein.
Analysis and characterization of Sbs
Western blot analysis was performed using goat antihuman Fc-HRP at 1:7500 dilution, biotinylated anti-human IL-2 at 1:2000 or anti-human IgA-HRP at 1:10 000. Gels containing IL-2 were detected with a second incubation of Avidin-HRP at 1:10 000. Blots were developed with Western Blot Detection Reagent (Amersham c/n RPN2209) and detected with X-ray film. Densitometry measurements of bands on gels and western blots were conducted using a Fujifilm LAS-4000 scanner and are given as the percentage of total protein measured in a given lane of a gel or blot.
Pharmacokinetic analysis
C57BL/6 mice (7 -8 weeks old) were injected with 25 mg of a SEED or wild-type fusion protein in a volume of 0.2 ml in the tail vein. At the indicated time points, small blood samples were taken by retro-orbital bleeding and collected in tubes coated with heparin to prevent clotting. After centrifugation to remove the cells, the plasma was assayed by capture with anti-human IgG H and L antisera, followed by detection with anti-human IL-2 (Gillies et al., 1998) (Sb Fc-IL2) or an anti-Fc (monovalent Fab-Sb Fc). Results were normalized to the initial concentration of the fusion protein in the serum of each mouse taken immediately after injection.
Results
In the cellular assembly of antibodies, the C H 3 domains have been shown to mediate heavy chain dimerization (Deisenhofer, 1981; Gillies and Wesolowski, 1990) . The Sb Fc analogues in this study comprise the following sequence: [N-terminal IgG1 hinge region] -C H 2 -SEED C H 3. Dimers that formed initially by non-covalent association are thus stabilized by interchain hinge disulfides that oxidize in the expressed Sb protein.
C H 3 domain sequence homology
We examined C H 3 sequences from a wide range of species to determine if homologous structural elements would suggest ways to create heterodimers. Most of the 19 residues of the b-strand interface in IgG C H 3 are homologous or identical in every species examined (Fig. 1) . The phylogenetically most distant of these species, the horn shark (Kokubu et al., 1988) , has only four non-homologous interface residues in its corresponding constant domain, despite divergence from humans over 400 million years ago.
In contrast, the different human Ig classes display a striking diversity of C H 3 contact surface residues. Figure 1 shows the alignment of the C-terminal constant domains of human immunoglobulin G with IgA, IgM and IgE. IgA is of particular interest, since its C H 3 retains an immunoglobulin fold that is structurally quite similar to that of IgG C H 3 (Herr et al., 2003) . In human IgA C H 3, 9 of its 19 interface residues exhibit no homology with their structural counterparts in IgG C H 3.
C H 3 dimer symmetry and interface contours
The C H 3 domains within the Fc region are oriented as crisscrossed dimers, with the pair of C-termini positioned on opposite sides of the dimer ( Fig. 2A and B) ; schematic diagrams of the domain orientation may be found in Supplementary Fig. 1A -S available at PEDS online. The C H 3 homodimer contact surfaces of IgA and IgG exhibit markedly different interdomain contours. There are four strands on the interface side of each domain, facing toward reader in In IgG C H 3 most of the six interface residues are hydrophilic, whereas in IgA C H 3 five of these six residues are not homologous with corresponding positions in IgG. Strand D in IgA has one very hydrophobic residue, Trp-398, in contrast to Thr-394 at that position in IgG. Trp-398 is the only aromatic hydrophobic side chain buried in the IgA C H 3 dimer interface. Strand E runs through the center of the interface and contains two aromatic side chains in IgG, Phe-405 and Tyr-407, which are fully buried upon self-association of the C H 3 to form a homodimer. Tyr-407 forms a symmetric aromatic ring interaction with its counterpart in the dimer and is a prominent feature of several IgG constant domain interfaces (Miller, 1990; Merchant et al., 1998) . In IgA, these positions have small side chains of relatively low hydrophobicity, Ala-412 and Thr-414.
Ca-backbone and hydrophobic core of IgA and IgG C H 3 domains Alignment of the human IgA and IgG C H 3 Ca-backbone atoms yielded an RMSD of 0.80 Å . The IgA C H 3 region is six amino acids longer than the IgG C H 3, and the additional residues lengthen three b-turns. An alignment without the turns resulted in an RMSD for the Ca-backbone of 0.57 Å , representing a high degree of homology between the seven b-strands. The C H 3 domain alignment also revealed strong conservation of their hydrophobic cores, including the positions of the intradomain disulfide bond and buried tryptophan. Ten identical residues (nine in the same rotamer orientation) form the hydrophobic core in each domain. The existence of strong homology between their domain cores and backbone structures reinforced the rationale for devising a strategy that combined elements of the IgA and IgG C H 3 domain structures.
Conversion of IgA and IgG C H 3 homodimers into Sb heterodimers
The creation of hybrid genes with multiple crossovers has been utilized in display libraries for selection of novel protein conformations (Meyer et al., 2006) . This investigation is the first to interdigitate alternating b-strand segments from distinct Ig domains for the rational design of complementary heterodimer contact surfaces, as displayed by the sequences in Fig. 3 (schematically shown in Supplementary Fig. 1B -S available at PEDS online). Structural alignment of the IgA and IgG domains along their 2-fold axes of symmetry generally indicated where to create the A-G or G -A crossover points ( Fig. 2A -F) . While they share crossover points, the two new domains differ in the order and composition of alternating b-strand segments from their parent domains, i.e. A 1 -G 2 -A 3 -G 4 . . . or G 1 -A 2 -G 3 -A 4 . . . for the AG and GA SEED C H 3 analogues, respectively, as defined in Fig. 3 (schematically depicted in Supplementary Fig. 1B -S available at PEDS online).
Human IgA and IgG C H 3 sequences are compared with the corresponding AG and GA SEED C H 3 sequences in Fig. 3 . Five of the seven junctions between A and G segments include at least one residue that is conserved between the two domains. The crossover points in strands D and G were chosen through modeling. We observed that if the strand D exchange point were placed between Trp-398 and Ala-399 in IgA, the Ala would convert to Pro-395 in the GA sequence. This could adversely impact the local backbone conformation, so the exchange point was shifted one residue to IgA Ser-400.
Distinct but complementary contact surfaces were created in the GA Sb and AG Sb C H 3 domain models, so that they would be expected to preferentially form heterodimers through the SEED C H 3 domain association ( Fig. 2G ) with little or no detectable homodimer ( Fig. 2H and I) . The b-sheets of opposing C H 3 subunits interact in a somewhat anti-parallel orientation that creates a broad interaction surface on either side of the homodimer 2-fold axis of symmetry. This configuration should likewise apply to the SEED C H 3 heterodimer (Fig. 2G ). The crossover junctions between A and G segments lie approximately along the original 2-fold axis of symmetry of the core residues in the parent domains. The contact surface of the native SEED C H 3 heterodimer will basically consist of two halves of native interactions, with one half consisting of the IgA homodimer and the other half IgG homodimer. In contrast, the interaction of both possible SEED C H 3 homodimers should be disfavored ( Fig. 2H and I ), relative to the heterodimer (Fig. 2G) . The surface contours of two SEED C H 3 contact surfaces sterically interfere when oriented as a homodimer, whereas they are highly complementary as the heterodimer.
Engineered FcRn and protein A binding sites in AG Sb
FcRn and rpA bind to IgG at the junction of the C H 2 and C H 3 domains, but neither binds to the IgA Fc region. In both cases, the binding site includes portions of the C H 3 solvent-accessible surface adjacent to the C H 2-C H 3 junction. Molecular models suggest that the AG Sb would not associate normally with FcRn or rpA, so the relevant surface residues of the AG SEED C H 3 were returned to the IgG sequence at the C H 2-AG C H 3 junction. These altered AG SEED C H 3 residues are underlined in Fig. 3 .
Characterization of Sb proteins
The formation of a heterodimeric Sb requires co-expression of two different gene products by a single host cell. To facilitate initial research, a separate vector was used for each gene in transient co expression. HEK-293T cells were transiently co-transfected with vectors for either AG Sb or GA Sb together with separate vectors for the complementary Sb-IL2. Long-term studies were conducted using protein from stably transfected NS/0 cell lines chosen for optimal Sb production. In order to assess how the different domains partition between Sb-Fc heterodimers and homodimers, we made alternative Sb-monocytokines and found the IL-2 fused to the C-terminus of the AG Sb was preferable for optimal production of the Sb monocytokine fusion protein.
After purification with rpA, the covalent dimer composition was determined under non-reducing conditions by SDS-PAGE, which separated different dimers crosslinked by their hinge disulfides, as well as uncrosslinked monomers (Fig. 4A ).
An asymmetric single Fab-Sb was also studied as a model system. Single Fab-Sb in the Fab-AG Sb . GA Sb format was produced by co-transfection of NS/0 cells with the expression vectors pdCs-GA Sb and the pdHL-Fab-AG Sb, which contains one transcription unit for the IgG light chain and another for the AG Sb heavy chain analogue (Gillies et al., 1989) . SDS -PAGE analysis of the expressed protein products under reducing conditions showed the presence of three polypeptides corresponding in size to the H chain (38% by densitometry), GA Sb (31%), and L chain (31%) (Fig. 4B, lane 2) . On a nonreducing gel, Fab-AG Sb . GA Sb heterodimer was the major species (52%), near the 98 kDa standard (Fig. 4B, lane 5) ; this percentage, as measured by densitometry, is probably a significant underestimate because the band is likely too intense to follow Beer's law; the lower band at 52 kDa is excess GA Sb . GA Sb homodimer (24%) which spontaneously dimerizes (Fig. 5, lane 11) when it cannot preferentially associate with AG Sb species. Expression of the corresponding control IgG1 using the pdHL vector, analyzed under reducing conditions, gave H (61%) and L (39%) bands (Fig. 4B,  lane 3) ; the H 2 L 2 tetramer is the only dominant band under non-reducing conditions (Fig. 4B, lane 6) , with an apparent MW that is slightly greater than that of monoFab-AG Sb . GA Sb in lane 5. To create this interface and heterodimer, the GA model (F) was rotated 180º around its vertical axis and then translated over the AG structure (E). Thus, GA (pink, light gray and lavender colors) is in the foreground of G, and AG (red, dark gray and blue colors) is in the background. In this figure, the strands and interface on the left half are derived from IgG C H 3 sequence, and the strands and interface on the right side are derived from IgA C H 3 sequence. In G, the C-and N-termini of the chains are noted as C-t and N-t, respectively, and the subunit is designated by AG or GA. 
Sb interaction experiments
The extent to which AG Sb or GA Sb C H 3 domains could interact with IgG and IgA C H 3 domains was assessed through co-expression of each Sb with either IgA or IgG Fc by mammalian cell expression. According to computer modeling studies, each SEED C H 3 should have unfavorable interdomain contacts over most of their C H 3 homodimer interface ( Fig. 2H and I (Fig. 5) , using both anti-IgG and anti-IgA detection antibodies. The GA Sb could still bind with the other constructs, including the IgG Fc (Fig. 5, lane 6) , and to associate as Sb C H 3 heterodimers or homodimers (Fig. 5, lanes 8 and 9,  respectively) 
Expression and yield of Sb heterodimer proteins
Production of fusion proteins as Fc-X is notable for its high level expression in mammalian cell culture (Lo et al., 1998) . We found that Sb heterodimers and fusion proteins were produced at levels equivalent to their Fc counterparts, yielding 20 and 100 mg/ml from transient or stable expression, respectively. In general, the yield of heterodimeric Sbs ranged from 85% to 95% of the total purified protein expressed by stably transfected cell lines.
Under optimal conditions with excess production of AG Sb-IL2 over GA Sb, the expressed GA Sb . AG Sb-IL2 that was purified with rpA exhibited ,1% of contaminating GA Sb . GA Sb homodimer. The extent of non-covalent aggregates was assessed by size exclusion chromatography (SEC), and monocytokine Sbs purified by rpA were compared with their corresponding Fc fusion proteins. SEC profiles showed little difference between the preparations, indicating the GA Sb . AG Sb-IL2 was a well-behaved heterodimer.
Pharmacokinetics
The results of the mouse pharmacokinetic (PK) studies show that the Sb proteins have the prolonged half-lives of the corresponding Fc-IL2 or Fab-Fc fusion proteins (Fig. 6) , which clearly reinforces the hypothesis that the Sb retains its FcRn binding activity, which is a critical effector function and is also consistent with its retention of the protein A binding capacity used for purification from culture supernatants. The GA Sb . AG Sb-IL2 had a slightly higher area under the curve than the control Fc-monomeric IL2 [AUC(0 -t) ¼ 304 and 215 mg h/ml, respectively] (Fig. 6A) . This is apparently due Fig. 3 . Primary sequence comparison of IgG, IgA and SEED C H 3 domain sequences, based on their structural alignment. Comparison of C H 3 sequences for human IgA, IgG, and SEED heterodimer domain sequences. In the absence of a consistent numbering system for these proteins, the following rules were followed: (i) EU numbering for IgG C H 3; (ii) PDB numbering (from 1OW0) for IgA C H 3. (iii) SEED C H 3 sequences are numbered sequentially from 1, with letters inserted to identify the locations of unequal loop length. Color code for horizontal bars that denote b-strands and for the sequences: blue is IgA-derived, red is IgG-derived, and black is common to both, usually along their axis of symmetry, which also designates where the sequence changes from one Ig class to the other. Tall print designates interface residues having a side chain atom within 4 Å of at least one atom in the partner chain, using the 1L6X crystal structure. Yellow vertical bands designate the 14 residues shared by the hydrophobic core of each domain. Alignment of these 14 residues (Ca) from 1OW0 and 1L6X give RMSD of 0.49 Å (using PyMOL). Red-underlined residues are those kept from IgG sequence in the AG SEED C H 3 domain, in order to maintain the integrity of its rpA and FcRn binding sites.
to a longer a-phase distribution half-life of 0.36 h (compared with 0.21 h for the control Fc-monomeric IL2), while both had a b-phase circulating half-life of 18.8 h. Interestingly, the PK profile of the monovalent antibody in the form of an Fab-AG Sb . GA Sb heterodimer was virtually identical to that of the bivalent wild-type IgG counterpart (Fig. 6B) , despite their large difference in molecular size and shape. An IgG-IL2 fusion protein (immunocytokine) containing the Sb was also shown to have PK equivalent to the control fusion protein (data not shown). Furthermore, Fab-AG Sb . GA Sb heterodimer was found to retain antibody-dependent cellular cytotoxicity activity in a standard assay (Gillies et al., 1992) . All these results are consistent with retention of critical Fc effector functions.
Discussion
Human Fc crystal structures display marked differences between the contours of inter-dimer contact surfaces for IgG and IgA C H 3 domains. Our structural analysis of these domains suggested a b-SEED strategy for construction of complementary C H 3 heterodimers. The symmetry of each pair of C H 3 homodimers provides for division along the major 2-fold axis of symmetry in the Fc region. SEED process-defined IgA and IgG segments (b-strand-turnb-strand) were exchanged in alternating motifs to form complementary heterodimers, comprising the AG and GA SEED C H 3 analogues within our model Sbs, GA Sb . AG Sb-IL2 and mono-Fab-AG Sb . GA Sb. We observed that although GA Sb forms homodimers when present in excess, the AG Sb does not dimerize with any species except GA Sb. Likewise, the AG Sb-IL2 was not detected in the culture supernatant in the absence of GA Sb. Nearly quantitative production of Sb heterodimers can be accomplished by ensuring a modest excess in expression of the AG Sb form over GA Sb during production in mammalian cells. It is interesting that non-specific GA Sb association correlates with a high density of interface aromatic residues, whereas in the AG Sb there are no aromatic residues at the core of the interface to cause steric effects, and there would be a minimal hydrophobic effect upon self-association compared with GA Sb. The preferential association of AG Sb and GA Sb stabilizes AG Sb, which emphasizes the importance of interface complementarity in conjunction with aromatic residue-mediated hydrophobic effects.
We have built upon the inherent differences between the C H 3 domains from human IgG and IgA, coupled with the somewhat anti-parallel geometry of C H 3 dimers. The resulting Sb heterodimers form in high yield before oxidation of the hinge disulfides creates covalent crosslinks between the separate Fc or H chains. The single-Fab and mono-IL2 Sbs produced in this study demonstrate that different functional groups may be incorporated in an Sb to satisfy particular therapeutic needs, including an enhanced circulating half-life following intravenous administration. The mono-Fab-Sb displayed the same circulating half-life as intact IgG, which emphasizes the importance of FcRn binding over the relative molecular weight and Stokes' radius of large proteins in determining clearance kinetics.
Sb Fc architecture provides for preferential heterodimer formation and retention of essential Fc properties. This allows a rapid first purification step with rpA, and fusion of the Sb Fc analogue to other proteins of interest solves the problem of half-life extension that is intrinsic to the use of small singlescaffold binding proteins, engineered forms of the intact antibody combining site such as the scFv, or V domain binders. reduced profile of control IgG shows H and L chain bands. Lane 4: protein standards. Lane 5: non-reduced profile shows major band of fully disulfide-crosslinked mono-Fab-AG Sb . GA Sb, with the much weaker but diffuse band above the 49 kDa marker that corresponds to GA Sb . GA Sb homodimer by-product that was co-purified by the rpA. Lane 6: non-reduced profile of control IgG shows major band of disulfide bridged H 2 L 2 .
The mono-Fab-Sb protein lends itself to construction of a bispecific by fusing an scFv to the N-terminus of the single truncated Sb chain, to yield a bispecific Sb that avoids the complications of producing mixtures of L chains in mammalian cell expression, which plagues quadromas. Alternatively, the symmetric fusion of distinct scFv antibody binding sites or single domain binders to each of the Sb Fc analogue chains could be a reliable and useful method for engineering bispecific Sbs. This is underscored by our PK studies of both Sb model proteins, following intravenous administration to mice. Clearly, the Sb Fc analogue region confers a significant half-life extension on the Sb proteins, equal within experimental error to the control antibody and IgG Fc immunofusion protein. This is indirect but strong evidence that the Sb binds to FcRn and is also consistent with the observed retention of protein A association by the overlapping region of the Sb structure. In summary, this investigation supports the viability of Sb engineering for the novel design and efficient production of bispecific, multispecific and asymmetric immunofusion proteins.
Supplementary data
Supplementary data are available at PEDS online.
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